Abstract：Objective To study the features of serum metabolites in preterm infants based on gas chromatographymass spectrometry (GC-MS), and to find differentially expressed metabolites in the serum of preterm infants. Methods Serum samples were collected from 19 preterm infants and 20 full-term infants before feeding. GC-MS was used to measure metabolic profles, and the metabolic features of 397 serum metabolites in preterm infants were analyzed. Results There was a signifcant difference in serum metabolic features between the preterm and full-term infants before feeding. There were significant differences between the full-term and preterm infants in the levels of metabolites such as O-phosphonothreonine, digicitrin, tannic acid, and fructose-1,6-diphosphate (P < 0.01), suggesting that the above differentially expressed metabolites were highly differentiated between the preterm and full-term infants. Most differentially expressed metabolites were involved in the metabolic pathways such as ABC transporters, β-alanine and pyrimidines and were correlated with some clinical parameters (albumin and total bilirubin) (P < 0.05). Conclusions There is a significant difference in serum metabolites between preterm and full-term infants before feeding. Metabolomics plays an important role in improving metabolic disorders and exploring metabolism-related diseases in preterm infants.
WANG Fu-Sheng,LI Wei-Zhong,WANG Guang-Huan et al. Serum metabolomics of preterm and full-term infants based on gas chromatography-mass spectrometry[J]. CJCP, 2019, 21(3): 259-264.
Helenius K, Sjörs G, Shah PS, et al. Survival in very preterm infants:an international comparison of 10 national neonatal networks[J]. Pediatrics, 2017, 140(6):e20171264.
[2]
Trembath AN, Payne AH, Colaizy TT, et al. The problems of moderate preterm infants[J]. Semin Perinatol, 2016, 40(6):370-373.
[3]
Hamosh M. Lipid metabolism in premature infants[J]. Biol Neonate, 1987, 52 Suppl 1:50-64.
Dudzik D, Barbas-Bernardos C, García A, et al. Quality assurance procedures for mass spectrometry untargeted metabolomics. a review[J]. J Pharm Biomed Anal, 2018, 147:149-173.
[6]
Rozance PJ. Glucose metabolism in the preterm infant[J]. J Pediatr, 2011, 158(6):874-875.
Hicks LC, Ralphs SJ, Williams HR. Metabonomics and diagnostics[J]. Methods Mol Biol, 2015, 1277:233-244.
[9]
Jelliffe-Pawlowski LL, Norton ME, Baer RJ, et al. Gestational dating by metabolic profle at birth:a California cohort study[J]. Am J Obstet Gynecol, 2016, 214(4):511.e1-511.e13.
Atzori L, Antonucci R, Barberini L, et al. Metabolomics:a new tool for the neonatologist[J]. J Matern Fetal Neonatal Med, 2009, 22(3):50-53.
[12]
Han C, Lu Y, Wei Y, et al. D-ribosylation induces cognitive impairment through RAGE-dependent astrocytic inflammation[J]. Cell Death Dis, 2014, 5:e1117.
[13]
Su T, He R. D-ribose, an overlooked player in type 2 diabetes mellitus?[J]. Sci China Life Sci, 2014, 57(3):361.
Jiang P, Trimigno A, Stanstrup J, et al. Antibiotic treatment preventing necrotising enterocolitis alters urinary and plasma metabolomes in preterm pigs[J]. J Proteome Res, 2017, 16(10):3547-3557.
[19]
Stewart CJ, Nelson A, Treumann A, et al. Metabolomic and proteomic analysis of serum from preterm infants with necrotising entercolitis and late-onset sepsis[J]. Pediatr Res, 2016, 79(3):425-431.
[20]
Dessì A, Pintus R, Marras S, et al. Metabolomics in necrotizing enterocolitis:the state of the art[J]. Expert Rev Mol Diagn, 2016, 16(10):1053-1058.
